Follow The Filings

CNO Cno Financial Group Inc.

Financials, filed as CNO FINL GROUP INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.3%
  • $109M
  • 1 reduce

In 2026 Q3 Richard Pzena trimmed Cno Financial Group.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Reduce 0.32%

Who owns CNO

Sorted by value, long equity only, as of 2026 Q3.

History
Richard Pzena, Pzena Investment Management 0.32%, was 0.37% Reduce −15.5% 2,064,300 $109M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CNO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CNO insider trades
  • None no insider bought on the open market
  • $2M sold by 1 insider outside a trading plan
  • $19.8M sold by 8 insiders under 10b5-1 plans
  1. Jeremy D. Williams Chief Actuary
    Planned sale
    $487K 8,782 shares at $55.49 13% of stake
    Traded Sep 15–16 Filed Sep 16
    ↗
  2. Jeanne L. Linnenbringer Chief Operations Officer
    Planned sale
    $799K 14,539 shares at $54.95 36% of stake
    Traded Aug 31–Sep 2 Filed Sep 2
    ↗
  3. Karen J. DeToro President, Worksite Division
    Planned sale
    $1.4M 24,674 shares at $54.92 40% of stake
    Traded Aug 31–Sep 2 Filed Sep 2
    ↗
  4. Gary C. Bhojwani CEO
    Planned sale
    $4.4M 86,048 shares at $51.48 33% of stake
    Traded Jun 30 Filed Jul 1
    ↗
  5. Rocco F. Tarasi III Chief Marketing Officer
    Planned sale
    $97K 1,891 shares at $51.31 2.4% of stake
    Traded Jul 1 Filed Jul 1
    ↗
  6. Rocco F. Tarasi III Chief Marketing Officer
    Planned sale
    $450K 9,058 shares at $49.63 10% of stake
    Traded Jun 10–11 Filed Jun 11
    ↗
  7. Rocco F. Tarasi III Chief Marketing Officer
    Planned sale
    $226K 4,808 shares at $47.00 5.5% of stake
    Traded Jun 2 Filed Jun 4
    ↗
  8. Scott L. Goldberg President, Consumer Division
    Planned sale
    $879K 22,120 shares at $39.76 9.3% of stake
    Traded Mar 19–20 Filed Mar 23
    ↗
  9. Yvonne K. Franzese Chief Human Resources Officer
    Planned sale
    $389K 9,000 shares at $43.17 20% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  10. Gary C. Bhojwani CEO
    Planned sale
    $3.8M 88,378 shares at $43.11 24% of stake
    Traded Feb 17–18 Filed Feb 18
    ↗
  11. Matthew J. Zimpfer General Counsel
    Planned sale
    $2.5M 57,370 shares at $43.10 16% of stake
    Traded Feb 17–18 Filed Feb 18
    ↗
  12. Scott L. Goldberg President, Consumer Division
    Planned sale
    $433K 17,095 shares at $25.34 11% of stake
    Traded Feb 10, 2023 Filed Feb 12
    ↗
  13. Matthew J. Zimpfer General Counsel
    Planned sale
    $1.3M 30,970 shares at $42.93 9.1% of stake
    Traded Feb 12 Filed Feb 12
    ↗
  14. Gary C. Bhojwani CEO
    Planned sale
    $1.3M 31,430 shares at $41.99 14% of stake
    Traded Jan 2 Filed Jan 2
    ↗
  15. Rocco F Tarasi III Chief Marketing Officer
    Planned sale
    $395K 9,283 shares at $42.60 11% of stake
    Traded Dec 15, 2025 Filed Dec 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 32 stock grants, 30 share withholdings for taxes, 13 option exercises, and 4 gifts.

Congress

2 members of Congress traded CNO in the last three years: 1 buy and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jun 11, 2025 filed Aug 13, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 9, 2025 filed Aug 13, 2025
  3. Jefferson Shreve R-IN-6 Sell $15K–$50K May 12, 2025 filed Jun 22, 2025

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 20 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.15B $4.45B $4.49B
Net income $276.5M $404M $229.3M
Net margin * 6.7% 9.1% 5.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $35.1B $37.85B $38.79B
Total equity $2.22B $2.5B $2.64B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $582.9M $627.7M $675.7M
Cash from investing -$0.872B -$1.49B -$1.67B
Cash from financing $0.534B $1.97B -$0.023B
Net change in cash $0.244B $1.11B -$1.01B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf